India’s pharmaceutical industry is currently valued at approximately US$58 billion, with projections indicating growth to US$120-130 billion by 2030 and US$400-450 billion by 2047. Key factors driving this expansion include the rising prevalence of lifestyle-related diseases, an aging population, increased focus on holistic health and well-being, and the growing consumerization of healthcare. India hosts the…